| scholarly article | Q13442814 |
| P50 | author | Alessandro Dessì | Q49838493 |
| Lieve Naesens | Q50551503 | ||
| Roberto Dallocchio | Q59172807 | ||
| P2093 | author name string | Mario Sechi | |
| Dominga Rogolino | |||
| Nicolino Pala | |||
| Annelies Stevaert | |||
| P2860 | cites work | The Protein Data Bank | Q24515306 |
| Anti‐infective properties of epigallocatechin‐3‐gallate (EGCG), a component of green tea | Q26852556 | ||
| Nucleoside Monophosphate Complex Structures of the Endonuclease Domain from the Influenza Virus Polymerase PA Subunit Reveal the Substrate Binding Site inside the Catalytic Center | Q27646520 | ||
| The structural basis for cap binding by influenza virus polymerase subunit PB2 | Q27650520 | ||
| Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site | Q27653656 | ||
| The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit | Q27653657 | ||
| Bunyaviridae RNA Polymerases (L-Protein) Have an N-Terminal, Influenza-Like Endonuclease Domain, Essential for Viral Cap-Dependent Transcription | Q27664646 | ||
| Structural and Biochemical Basis for Development of Influenza Virus Inhibitors Targeting the PA Endonuclease | Q27671357 | ||
| Structural Analysis of Specific Metal Chelating Inhibitor Binding to the Endonuclease Domain of Influenza pH1N1 (2009) Polymerase | Q27671365 | ||
| Organization of the influenza virus replication machinery | Q27675228 | ||
| Crystal structure of Prp8 reveals active site cavity of the spliceosome | Q27676016 | ||
| The structure of native influenza virion ribonucleoproteins | Q27683510 | ||
| 3-Hydroxyquinolin-2(1 H )-ones As Inhibitors of Influenza A Endonuclease | Q27684365 | ||
| Mapping the protein universe | Q27861112 | ||
| A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription | Q27865288 | ||
| Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds | Q28368059 | ||
| A novel antiviral agent which inhibits the endonuclease of influenza viruses | Q28378972 | ||
| Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors | Q28378984 | ||
| Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerase | Q28471610 | ||
| Anti-influenza activity of marchantins, macrocyclic bisbibenzyls contained in liverworts | Q28478205 | ||
| AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility | Q29547658 | ||
| A semiempirical free energy force field with charge-based desolvation | Q29614316 | ||
| Python: a programming language for software integration and development | Q29614317 | ||
| Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic | Q29619055 | ||
| Structures of influenza A proteins and insights into antiviral drug targets. | Q30387969 | ||
| Reassortment and mutation of the avian influenza virus polymerase PA subunit overcome species barriers | Q30409567 | ||
| Influenza research database: an integrated bioinformatics resource for influenza research and surveillance. | Q30411991 | ||
| Identification of Influenza Endonuclease Inhibitors Using a Novel Fluorescence Polarization Assay | Q30574395 | ||
| Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters | Q31431626 | ||
| Synthesis of natural flutimide and analogous fully substituted pyrazine-2,6-diones, endonuclease inhibitors of influenza virus | Q31943359 | ||
| Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin | Q33826751 | ||
| Developing new antiviral agents for influenza treatment: what does the future hold? | Q34015113 | ||
| Influenza A virus polymerase: structural insights into replication and host adaptation mechanisms | Q34121115 | ||
| Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide | Q34637724 | ||
| Mortality benefits of influenza vaccination in elderly people: an ongoing controversy | Q34693675 | ||
| Global transmission of oseltamivir-resistant influenza | Q34955928 | ||
| Globin mRNAs are primers for the transcription of influenza viral RNA in vitro | Q35994818 | ||
| Sequence, structure and functional diversity of PD-(D/E)XK phosphodiesterase superfamily | Q36180207 | ||
| Endonuclease substrate selectivity characterized with full-length PA of influenza A virus polymerase | Q36825882 | ||
| The influenza virus RNA synthesis machine: advances in its structure and function | Q37847896 | ||
| Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir). | Q38339478 | ||
| Mode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1 | Q38342030 | ||
| Intracytoplasmic trapping of influenza virus by a lipophilic derivative of aglycoristocetin. | Q39323887 | ||
| Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells | Q39355418 | ||
| Synthesis and biological evaluation of pyrimidine nucleoside monophosphate prodrugs targeted against influenza virus | Q39401526 | ||
| Generation of Recombinant Influenza Virus from Plasmid DNA | Q39664696 | ||
| Anti-influenza activity of phenethylphenylphthalimide analogs derived from thalidomide | Q39694651 | ||
| PA subunit of RNA polymerase as a promising target for anti-influenza virus agents | Q40015466 | ||
| The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase | Q40517134 | ||
| Comparative study of influenza virus replication in Vero and MDCK cell lines | Q40539053 | ||
| Design and synthesis of novel dihydroxyindole-2-carboxylic acids as HIV-1 integrase inhibitors | Q40547803 | ||
| Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors | Q40662853 | ||
| Unidirectional RNA polymerase I-polymerase II transcription system for the generation of influenza A virus from eight plasmids | Q40841255 | ||
| Binding mode prediction and inhibitor design of anti-influenza virus diketo acids targeting metalloenzyme RNA polymerase by molecular docking | Q42049688 | ||
| Mutational and metal binding analysis of the endonuclease domain of the influenza virus polymerase PA subunit | Q42428242 | ||
| Amino acid residues in the N-terminal region of the PA subunit of influenza A virus RNA polymerase play a critical role in protein stability, endonuclease activity, cap binding, and virion RNA promoter binding | Q43156905 | ||
| Metal-dependent inhibition of HIV-1 integrase by beta-diketo acids and resistance of the soluble double-mutant (F185K/C280S). | Q44550618 | ||
| From ligand to complexes: inhibition of human immunodeficiency virus type 1 integrase by beta-diketo acid metal complexes. | Q44619681 | ||
| Design of novel bioisosteres of beta-diketo acid inhibitors of HIV-1 integrase | Q45288657 | ||
| Metal ion catalysis of RNA cleavage by the influenza virus endonuclease | Q45749822 | ||
| Design and synthesis of bis-amide and hydrazide-containing derivatives of malonic acid as potential HIV-1 integrase inhibitors. | Q46335921 | ||
| Investigating the role of metal chelation in HIV-1 integrase strand transfer inhibitors | Q54551751 | ||
| Design, synthesis, molecular modeling, and anti-HIV-1 integrase activity of a series of photoactivatable diketo acid-containing inhibitors as affinity probes. | Q54774966 | ||
| A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS | Q107473800 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mutational analysis | Q1955810 |
| binding pocket | Q61659196 | ||
| P304 | page(s) | 10524-38 | |
| P577 | publication date | 2013-10-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Mutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonuclease | |
| P478 | volume | 87 |
| Q64239050 | Q64239050 |
| Q41867513 | 3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant. |
| Q30390167 | A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In Vitro |
| Q36666497 | A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase. |
| Q93028017 | Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference |
| Q26738562 | Antiviral therapies on the horizon for influenza |
| Q61814222 | Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons |
| Q28833828 | Chemical Genomics Identifies the PERK-Mediated Unfolded Protein Stress Response as a Cellular Target for Influenza Virus Inhibition |
| Q38299435 | Cross-protection of influenza A virus infection by a DNA aptamer targeting the PA endonuclease domain. |
| Q54210628 | Crystal structures of Lymphocytic choriomeningitis virus endonuclease domain complexed with diketo-acid ligands. |
| Q40559394 | Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis. |
| Q42103503 | Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virus |
| Q36049626 | Fragment-Based Identification of Influenza Endonuclease Inhibitors |
| Q36770792 | Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor. |
| Q52565527 | Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors |
| Q90689822 | Influenza A and B viruses with reduced baloxavir susceptibility display attenuated in vitro fitness but retain ferret transmissibility |
| Q64065291 | Inhibition of avian-origin influenza A(H7N9) virus by the novel cap-dependent endonuclease inhibitor baloxavir marboxil |
| Q38839349 | Investigation of the salicylaldehyde thiosemicarbazone scaffold for inhibition of influenza virus PA endonuclease |
| Q47886776 | Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses |
| Q37166751 | N-acylhydrazone inhibitors of influenza virus PA endonuclease with versatile metal binding modes |
| Q30234943 | Progress of small molecular inhibitors in the development of anti-influenza virus agents |
| Q40238930 | Slow but Steady Wins the Race: Dissimilarities among New Dual Inhibitors of the Wild-Type and the V27A Mutant M2 Channels of Influenza A Virus |
| Q60046097 | Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil |
| Q28071809 | The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design |
| Q38963385 | The PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses |
| Q35960631 | Virtual Screening and Biological Validation of Novel Influenza Virus PA Endonuclease Inhibitors. |
Search more.